Teleflex announced today that it entered into a definitive agreement to acquire Palette Life Sciences. The deal to acquire the privately-held urology technology developer includes an upfront cash payment of $600 million at closing. It also includes up to an additional $50 million upon the achievement of certain commercial milestones. Wayne, Pennsylvania-based Teleflex said in […]
Urology
Study backs Olympus iTind for treating enlarged prostate
Olympus today announced positive study data for its minimally invasive iTind treatment for symptoms of enlarged prostate. The iTind procedure involves the placement of a temporary implanted nitinol device that reshapes the prostatic urethra. It does this without burning or cutting the prostate. Device placement can occur in an outpatient setting or physician’s office. The […]
FDA approves drug-coated balloon for BPH symptoms from Urotronic
Urotronic announced that the FDA approved its Optilume BPH catheter system for to alleviate urinary symptoms caused by BPH. Minneapolis-based Urotronic designed Optilume as a minimally invasive surgical therapy. It combines mechanical dilation using a proprietary double-lobe balloon with concurrent localized delivery of paclitaxel. This treats lower urinary tract symptoms secondary to BPG (benign prostatic […]
Smart implant from UroMems meets primary endpoint in first-in-human study
UroMems announced that it successfully met the primary endpoints for the initial male patient in a study of its UroActive smart implant. Grenoble, France-based UroMems develops mechatronics technology to treat stress urinary incontinence (SUI). Its SOPHIA study evaluates the UroActive smart, automated artificial urinary sphincter (AUS) in the treatment of SUI. The company plans for […]
Boston Scientific won’t buy majority stake in M.I. Tech
Boston Scientific (NYSE:BSX) will no longer be acquiring a majority stake in Korea-based medical device manufacturer M.I. Tech. The Marlborough, Massachusetts-based company announced plans to acquire a 64% stake in M.I. Tech in June 2022. It valued the deal at approximately $230 million. At the time, the company expected to close the transaction by the end […]
UroMems picks up FDA STeP designation for smart implant that treats urinary incontinence
UroMems announced that it received Safer Technologies Program (STeP) designation from the FDA for its UroActive smart continence therapy. STeP, a collaborative program, helps reduce the time needed to develop and obtain marketing authorization for eligible devices. FDA launched STeP in 2021, modeling the program on its breakthrough devices designation program. STeP covers devices that […]
Teleflex announces new positive research for UroLift system
Teleflex (NYSE:TFX) today announced new research from multiple studies supporting the prostatic urethral lift (PUL) procedure with its UroLift system. Wayne, Pennsylvania-based Teleflex designed UroLift to treat men with benign prostatic hyperplasia (BPH). It presented data at the 38th Annual European Association of Urology (EAU) Congress in Milan, Italy. The company said in a news […]
Interventional Systems announces endourology venture with surgical robot tech
Interventional Systems announced a new venture — called LARC Robotics — aimed at using surgical robotics for percutaneous renal access. Austria-based Interventional Systems said the unit simplifies percutaneous renal access in percutaneous nephrolithotomy (PCNL) procedures. This minimally invasive surgical technique helps to manage kidney stones. The company said in a news release that Dr. Udo […]
Minerva Surgical closes $30M financing, has new controlling stockholder
Minerva Surgical (Nasdaq:UTRS) announced today that it closed a private placement worth approximately $30 million. Santa Clara, California-based Minerva sold more than 146.6 million shares of its common stock at $0.0246 per share. Accelmed Partners led the private placement with participation by New Enterprise Associates. The financing makes Accelmed the controlling stockholder of Minerva Surgical. […]
J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform
Ethicon, a Johnson & Johnson MedTech company, today announced the first robotic-assisted removal of kidney stones using the Monarch platform. Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022. The University of California, Irvine’s UCI Health used the Monarch platform for urology to complete the first procedure. According […]
FDA clears single-use ureteroscope system from Boston Scientific
Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its LithoVue Elite single-use ureteroscope system. Marlborough, Massachusetts-based Boston Scientific plans a limited U.S. launch for the digital, flexible ureteroscope system in the coming weeks. The company said in a news release that it’s the first ureteroscope system that can monitor intrarenal pressure […]